STERILE ABSCESSES IN GLIOMA PATIENTS TREATED BY INTRAPARENCHYMAL INJECTION OF LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 - CASE-REPORTS

被引：8

作者：

ATKINSON, LL

MERCHANT, RE

GHATAK, NR

YOUNG, HF

机构：

[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT ANAT,MCV STN,BOX 709,RICHMOND,VA 23298

[2] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,RICHMOND,VA 23298

[3] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PATHOL,RICHMOND,VA 23298

来源：

NEUROSURGERY | 1989年 / 25卷 / 05期

关键词：

D O I：

10.1227/00006123-198911000-00019

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：805 / 810

页数：6

共 38 条

[11] INCREASED VASCULAR-PERMEABILITY IN ORGANS MEDIATED BY THE SYSTEMIC ADMINISTRATION OF LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 IN MICE [J].

ETTINGHAUSEN, SE ;

PURI, RK ;

ROSENBERG, SA .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (03) :177-188

[12] IMMUNOMODULATORS IN CLINICAL MEDICINE [J].

FAUCI, AS ;

ROSENBERG, SA ;

SHERWIN, SA ;

DINARELLO, CA ;

LONGO, DL ;

LANE, HC .

ANNALS OF INTERNAL MEDICINE, 1987, 106 (03) :421-433

[13] THE DIFFERENTIAL INHIBITORY EFFECTS EXERTED BY CYCLOSPORINE AND HYDROCORTISONE ON THE ACTIVATION OF HUMAN CYTO-TOXIC LYMPHOCYTES BY RECOMBINANT INTERLEUKIN-2 VERSUS ALLOSPECIFIC CTL [J].

GRIMM, EA ;

MUUL, LM ;

WILSON, DJ .

TRANSPLANTATION, 1985, 39 (05) :537-540

[14]

GRIMM EA, 1984, LYMPHOKINES, V9, P279

[15]

JACOBS SK, 1986, CANCER RES, V46, P2101

[16] INVITRO KILLING OF HUMAN GLIOBLASTOMA BY INTERLEUKIN-2-ACTIVATED AUTOLOGOUS LYMPHOCYTES [J].

JACOBS, SK ;

WILSON, DJ ;

KORNBLITH, PL ;

GRIMM, EA .

JOURNAL OF NEUROSURGERY, 1986, 64 (01) :114-117

[17] CYCLOSPORIN-A INHIBITS T-CELL GROWTH-FACTOR GENE-EXPRESSION AT THE LEVEL OF MESSENGER-RNA TRANSCRIPTION [J].

KRONKE, M ;

LEONARD, WJ ;

DEPPER, JM ;

ARYA, SK ;

WONGSTAAL, F ;

GALLO, RC ;

WALDMANN, TA ;

GREENE, WC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (16) :5214-5218

[18] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS [J].

LOTZE, MT ;

CHANG, AE ;

SEIPP, CA ;

SIMPSON, C ;

VETTO, JT ;

ROSENBERG, SA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22) :3117-3124

[19]

MCVICAR DW, 1989, CANCER IMMUNOL IMMUN, V29, P211

[20] INTRALESIONAL INFUSION OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) FOR THE TREATMENT OF PATIENTS WITH MALIGNANT BRAIN-TUMOR [J].

MERCHANT, RE ;

MERCHANT, LH ;

COOK, SHS ;

MCVICAR, DW ;

YOUNG, HF .

NEUROSURGERY, 1988, 23 (06) :725-732

← 1 2 3 4 →